Norethindrone Acetate And Ethinyl Estradiol, And Ferrous Fumarate Kit
Product Images NDC 69238-1686

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol, And Ferrous Fumarate (NDC 69238-1686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinyl Estradiol Structural Formula (Norethindrone Acetate And Ethinyl Estradiol Capsul 1)

Chemical structure diagram of Ethinyl Estradiol, one of the active ingredients in the product Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate. The structure shows a steroid framework with hydroxyl and alkyne functional groups.*

FDA Label Image

Norethindrone Acetate Structural Formula (Norethindrone Acetate And Ethinyl Estradiol Capsul 2)

Chemical structure of Norethindrone Acetate, showing a steroid-based molecular framework with various functional groups including a ketone, an acetate ester, and an alkyne moiety.*

FDA Label Image

Figure 1 (Norethindrone Acetate And Ethinyl Estradiol Capsul 3)

A pharmacokinetic concentration-time graph showing norethindrone concentration (pg/mL) on the y-axis versus time (hours) on the x-axis. Two curves compare Day 1 and Day 24 drug levels, illustrating fluctuations in norethindrone concentration over a 60-hour period.*

FDA Label Image

Figure 2 (Norethindrone Acetate And Ethinyl Estradiol Capsul 4)

A line graph showing ethinyl estradiol concentration (pg/mL) in plasma over time (hours) on Day 1 and Day 24. The curves illustrate higher peak concentrations and prolonged levels on Day 24 compared to Day 1, with concentration declining after peaking within a few hours.*

FDA Label Image

Chart (Norethindrone Acetate And Ethinyl Estradiol Capsul 5)

An illustration showing a vertical arrow labeled with pregnancy frequency, indicating 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom. It categorizes various birth control methods by effectiveness, listing 'Implants, Injections, Intrauterine devices, Sterilization' at the top, followed by 'Birth control pills, Skin patch, Vaginal ring with hormones,' 'Condoms, Diaphragm,' 'No sex during the most fertile days, Spermicide, Withdrawal,' and 'No birth control' at the bottom associated with the highest pregnancy rates per 100 women per year.*

FDA Label Image

Pill Pack (Norethindrone Acetate And Ethinyl Estradiol Capsul 6)

An instructional diagram for a 28-day oral contraceptive kit containing Norethindrone Acetate and Ethinyl Estradiol capsules, along with Ferrous Fumarate capsules. The pill layout is organized by day of the week (Sunday to Saturday) and by week (1 to 4). Arrows indicate the direction to take the pills from left to right each week. Instructions are provided for Sunday starters and Day-1 starters on where to begin taking the pills. The Amneal Pharmaceuticals LLC logo is visible below the pill grid.*

FDA Label Image

Carton (Norethindrone Acetate And Ethinyl Estradiol Capsul 7)

Packaging label for Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg, in a 28-day regimen kit. The label includes the product name, strength, directions indicating 24 days of active therapy, and states it is manufactured by Amneal Pharmaceuticals LLC. The label design features the Amneal logo and barcode, with areas designated for lot number, expiration date, and serialization.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.